Micropep Technologies, a deep tech startup specialized in plant biotechnologies, announces today the appointment of Kevin Smith as non-executive Chairman of its newly created Board of Directors. He will serve on the Board alongside 3 additional former CEOs from well-known plant biotechnology companies: Alain Godard, Eric Rey and Luc Mathis. Following the capital investment of 4 million euros by Sofinnova Partners and Irdi Soridec Gestion in March 2018, Micropep strengthened by 4 international experts has created the best possible conditions for success.
Kevin Smith, a 30-year veteran in international business, is nominated as Chairman of the Board
Created in 2016, Micropep Technologies is a deep tech plant biotechnology startup developing a new generation of crop stimulation and crop protection solutions based on a disruptive technology: “miPEP”, natural plant peptides transiently regulating gene expression.
The company today announces the appointment of Kevin Smith as non-executive Chairman of its newly formed Board of Directors. Kevin is a hands-on multicultural leader with a proven and strong track record in building highly profitable businesses by developing, communicating and aligning multicultural teams around a vision and executing profitable customer solutions growth strategies. Between 2008 and 2014, he led Arysta Lifescience European and EAM businesses as regional CEO, where he doubled profits while building Arysta’s global biologicals solutions portfolio. He is currently Senior Vice President at Houghton International, world number 1 in metalworking fluids. As a world-renowned expert with more than 30 years of experience in management and coaching of executive teams, his role is to fast-track the development of Micropep Technologies.
Kevin says: ‘I am thrilled to join Micropep’s new Board of Directors as non-executive chairman. My ambition is to help this highly innovative and ambitious startup to transform its disruptive and groundbreaking technology into a competitive portfolio of efficient solutions for agriculture. I am proud to offer my experience and leadership skills to support this unique company which lies at the crossroads between plant genetics and crop stimulation and protection solutions.’
Alain Godard, Eric Rey and Luc Mathis join Micropep’s first Board of Directors as independent members
Alongside Kevin’s nomination, the company appointed
three other independent board members with incomparable
hands-on experience in the Agricultural Biotechnology sector: Alain
Godard, former CEO of Aventis
CropScience (acquired by Bayer in 2002),
Eric Rey, former
CEO of Arcadia Bioscience (NASDAQ:RKDA) – a leading
company of agricultural traits
for heathier products
-, and Luc Mathis, former
CEO of Calyxt (NASDAQ:CLXT) – a leading
company in gene editing
for agriculture. Their
complementary skills and experience in both plant
genetics and crop protection
as well as their significative international track-record will support Micropep’s ambition to quickly
emerge as a global
leading biotechnology company
in the agricultural sector.
Micropep’s Board of Directors is further composed of Thomas Laurent, co-founder and CEO, and of the representatives of Sofinnova Partners (Denis Lucquin) and Irdi Soridec (Jean-Michel Petit), the two main investors.
“I am really excited by the broad and unique experience brought to Micropep by each of our board member. I feel lucky to be able to work with 4 former CEOs, each bringing their own set of expertise and skills to help us address all the challenges lying ahead of us. We are working hard on developing an ambitious and truly disruptive technology to help address one of the biggest challenges of the 21st century: to develop a both productive and environmentally friendly agriculture, and I am convinced that our board members’ experience will help us progress faster towards this goal” comments Thomas Laurent, CEO of Micropep Technologies.